Bizotic Commercial IPO vs Cell Point IPO

Comparison between Bizotic Commercial IPO and Cell Point IPO.

IPO Details

Bizotic Commercial IPO is a SME Fixed Price IPO proposed to list at BSE SME while Cell Point IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Bizotic Commercial IPO is up to ₹40.10 Cr whereas the issue size of the Cell Point IPO is up to ₹47.82 Cr. The final issue price of Bizotic Commercial IPO is ₹175.00 per share and of Cell Point IPO is ₹100.00 per share.

 Bizotic Commercial IPOCell Point IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹175.00 per share₹100.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size800 shares1200 shares
Fresh Issue Size22,91,200 shares47,82,000 shares
Fresh Issue Size (Amount)up to ₹40.10 Crup to ₹47.82 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total22,91,200 shares47,82,000 shares
Issue Size Total (Amount)up to ₹40.10 Crup to ₹47.82 Cr

IPO Timetable

Bizotic Commercial IPO opens on Jun 12, 2023, while Cell Point IPO opens on Jun 15, 2023. The closing date of Bizotic Commercial IPO and Cell Point IPO is Jun 15, 2023, and Jun 20, 2023, respectively.

 Bizotic Commercial IPOCell Point IPO
Issue OpenJun 12, 2023Jun 15, 2023
Issue CloseJun 15, 2023Jun 20, 2023
Basis Of Allotment (Tentative)Jun 20, 2023Jun 23, 2023
Initiation of Refunds (Tentative)Jun 21, 2023Jun 26, 2023
Credit of Share (Tentative)Jun 22, 2023Jun 27, 2023
Listing date (Tentative)Jun 23, 2023Jun 28, 2023

Financials & KPIs

Bizotic Commercial IPO P/E ratio is 36.38, as compared to Cell Point IPO P/E ratio of 24.1.

 Bizotic Commercial IPOCell Point IPO
Financials

Company Financials (Restated)

Period Ended31 Dec 202231 Mar 202231 Mar 202131 Mar 2020
Assets39.7337.3818.9811.02
Total Income37.4953.4216.8011.14
Profit After Tax2.900.600.340.16
NET Worth8.661.230.640.30
Reserves and Surplus3.031.220.630.29
Total Borrowing3.692.56
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Dec 202231 Mar 202231 Mar 202131 Mar 2020
Assets90.6482.7065.3155.85
Total Income221.68270.04223.56278.12
Profit After Tax5.811.650.691.60
NET Worth19.1713.3611.7111.02
Reserves and Surplus5.5212.2210.589.88
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.99%100%
Promoter Shareholding (Post-Issue)69.99%73.06%
P/E Ratio36.3824.1
Market Cap₹140.70 Cr.₹186.86 Cr.
EPS₹0.82₹11.60
RoNW51.2710.55

Shares Offered

In the Bizotic Commercial IPO Retail Individual Investors (RII) are offered 11,45,600 shares while in Cell Point IPO retail investors are offered 11,45,600 shares. Qualified Institutional Buyers (QIB) are offered in Bizotic Commercial IPO and in Cell Point IPO.

 Bizotic Commercial IPOCell Point IPO
Market Maker Reservation1,20,800 shares2,52,000 shares
NII11,45,600 shares23,91,000 shares
RII11,45,600 shares23,91,000 shares
Total22,91,200 shares47,82,000 shares

Bids Received (Subscription)

Bizotic Commercial IPO subscribed 1.87x in total, whereas Cell Point IPO subscribed 6.01x.

 Bizotic Commercial IPOCell Point IPO
NII (times)2.00x4.11x
RII (times)1.74x7.92x
Total (times)1.87x6.01x

Compare with others

Compare:

Bizotic Commercial IPO Vs Cell Point IPO